1.
Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa, Asuka Oda, Ariunzaya Bat-Erdene, Takeshi Harada, Shingen Nakamura, Mohannad Ashtar, So Shimizu, Masami Iwasa, Kimiko Sogabe, Masahiro Oura, Shiro Fujii, Kumiko Kagawa, Hirokazu Miki, Itsuro Endo, Tatsuji Haneji, Toshio Matsumoto, Masahiro Abe. TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma. haematol [Internet]. 2021Apr.30 [cited 2024Apr.19];106(5):1401-13. Available from: https://haematologica.org/article/view/9713